[1] ZHANG L,YAN J,LIU X,et al. Pharmacovigilance practice and risk control of traditional Chinese medicine drugs in China:current status and future perspective[J]. J Ethnopharmacol,2012,140(3):519-525. [2] 康瑞霞,游蓉丽,王蕾,等. 中药注射剂过敏反应体外实验研究进展[J]. 中国中药杂志,2015,40(13):2503-2507. [3] LIN N,LIU T,LIN L,et al. Comparison of in vivo immunomodulatory effects of 5-hydroxymethylfurfural and 5,5'-oxydimethylenebis (2-furfural)[J]. Regul Toxicol Pharmacol, 2016,81:500-511. [4] 陶玉华,邓春杰,王景佳,等. 丹香冠心注射液致严重过敏反应1例报告[J]. 亚太传统医药,2011,7(8):72-73. [5] 马丹华,席蓉,孙骏. 生脉注射液不良反应特征及影响因素[J]. 药学与临床研究,2016,24(4):324-327. [6] 孙丽,唐汉武. 178例脉络宁注射液不良反应的文献分析[J]. 中国药物警戒,2016,13(3):169-172. [7] 臧清策,何菁菁,白进发,等. 快速筛查中药注射液中有害物质5-羟甲基糠醛的LC-MS/MS方法及其质量评价研究[J]. 药学学报,2013,48(11):1705-1709. [8] ZANG Q,GAO Y,HUANG L,et al. Rapid and sensitive liquid chromatography-tandem mass spectrometric method for the quantitative determination of potentially harmful substance 5,5'-oxydimethylenebis (2-furfural) in traditional Chinese medicine injections[J]. Acta Pharmaceutica Sinica B,2018,8(2):235-241. [9] WHRITENOUR J,COLE S,XU Z,et al. Development and partial validation of a mouse model for predicting drug hypersensitivity reactions[J]. J Immunotoxicol,2014,11(2):141-147. [10] KWAST L M,FIECHTER D,HASSING I,et al. Oral exposure to drugs with immune-adjuvant potential induces hypersensitivity responses to the reporter antigen TNP-OVA[J]. Toxicol Sci,2011,121(2):312-319. [11] LIU Z,LIU Z,SHI Y,et al. Evaluation of the immunosensitizing potential of chlorogenic acid using a popliteal lymph node assay in BALB/c mice[J]. Food Chem Toxicol,2010,48(4):1059-1065. [12] XU J,FU S,PENG W,et al. MCP-1-induced protein-1,an immune regulator[J]. Protein Cell,2012,3(12):903-910. [13] 王宏,刘兆华,杜武等. 腘窝淋巴结试验模型的构建及在清开灵注射液致敏性研究中的应用[J]. 中国药理学与毒理学杂志,2012,26(2):183-188. |